Pharmacovigilance experts Cyle Connell and Ellen O'Dea of Deloitte Consulting LLP will lead a session on October 28, 2026, to address the mounting pressure on safety operations. The discussion focuses on transitioning from traditional manual classification to AI-driven workflows that prioritize auditability and end-to-end traceability. The presenters will showcase ElevateSafety™ and Detective, tools powered by the Converge™ by Deloitte platform, to illustrate how automated data structuring and quality checks function in a real-world, regulated environment.
In section Releases
Scaling Pharmacovigilance: Deloitte Leaders to Demo AI Case Intake
As adverse event reports flood in from emails, portals, and chatbots, pharmaceutical teams struggle to process the surge without drowning in manual reviews. A forthcoming Xtalks webinar aims to bridge this gap by demonstrating how artificial intelligence can automate data intake while maintaining rigorous human oversight and regulatory compliance.
The core challenge remains balancing efficiency with accountability. By embedding confidence indicators and transparent quality controls directly into the intake process, teams can redirect expert attention toward the most complex safety signals. Whether organizations are just beginning to evaluate AI or seeking to benchmark current systems, the webinar provides a practical blueprint for integrating machine intelligence into life sciences safety operations without compromising the human expertise required for critical decision-making.
Comments (0)
No comments yet. Be the first!